MariMed Inc (MRMD)
0.2551
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
MariMed Enterprise Value: 148.43M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 148.43M |
| May 15, 2024 | 148.01M |
| May 14, 2024 | 148.39M |
| May 13, 2024 | 152.19M |
| May 10, 2024 | 151.24M |
| May 09, 2024 | 156.02M |
| May 08, 2024 | 161.75M |
| May 07, 2024 | 163.58M |
| May 06, 2024 | 161.44M |
| May 03, 2024 | 165.47M |
| May 02, 2024 | 164.60M |
| May 01, 2024 | 166.98M |
| April 30, 2024 | 174.86M |
| April 29, 2024 | 154.02M |
| April 26, 2024 | 152.73M |
| April 25, 2024 | 152.95M |
| April 24, 2024 | 149.65M |
| April 23, 2024 | 148.80M |
| April 22, 2024 | 148.55M |
| April 19, 2024 | 154.02M |
| April 18, 2024 | 156.48M |
| April 17, 2024 | 153.50M |
| April 16, 2024 | 154.40M |
| April 15, 2024 | 150.22M |
| April 12, 2024 | 147.32M |
| Date | Value |
|---|---|
| April 11, 2024 | 149.20M |
| April 10, 2024 | 152.88M |
| April 09, 2024 | 148.75M |
| April 08, 2024 | 150.33M |
| April 05, 2024 | 149.22M |
| April 04, 2024 | 146.57M |
| April 03, 2024 | 151.34M |
| April 02, 2024 | 140.75M |
| April 01, 2024 | 146.95M |
| March 31, 2024 | 150.73M |
| March 28, 2024 | 149.05M |
| March 27, 2024 | 152.21M |
| March 26, 2024 | 147.75M |
| March 25, 2024 | 151.24M |
| March 22, 2024 | 155.78M |
| March 21, 2024 | 146.59M |
| March 20, 2024 | 146.40M |
| March 19, 2024 | 146.78M |
| March 18, 2024 | 153.15M |
| March 15, 2024 | 147.53M |
| March 14, 2024 | 135.90M |
| March 13, 2024 | 129.33M |
| March 12, 2024 | 126.56M |
| March 11, 2024 | 136.14M |
| March 08, 2024 | 143.74M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
67.23M
Minimum
Mar 12 2020
695.48M
Maximum
May 20 2019
203.85M
Average
186.57M
Median
Enterprise Value Benchmarks
| Emergent BioSolutions Inc | 1.104B |
| Zymeworks Inc | 318.16M |
| Viemed Healthcare Inc | 273.66M |
| NovaBay Pharmaceuticals Inc | 5.209M |
| Palatin Technologies Inc | 23.43M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.298M |
| Revenue (Quarterly) | 37.93M |
| Total Expenses (Quarterly) | 35.83M |
| EPS Diluted (Quarterly) | -0.0035 |
| Gross Profit Margin (Quarterly) | 43.42% |
| Profit Margin (Quarterly) | -3.42% |
| Earnings Yield | -14.16% |
| Operating Earnings Yield | 12.69% |
| Normalized Earnings Yield | -4.951 |